DP VII ASSOCIATES LP Insider Trading $CLVS Clovis Oncology, Inc.
Get free email notifications about insider trading for DP VII ASSOCIATES LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DP VII ASSOCIATES LP. DP VII ASSOCIATES LP is 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in OBALON THERAPEUTICS INC ($OBLN) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Neothetics, Inc. ($NEOT).
DP VII ASSOCIATES LP in Clovis Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DP VII ASSOCIATES LP: 10% Owner
Holdings: 44,034 shares
Current Value: $2,642,040
Latest Transaction: Jun 05 2013
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DP VII ASSOCIATES LP in Clovis Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, CADX, CLVS, ESPR, NEOT, EVOK, OREX, OBLN, TNDM, TBRA, ZGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 64.58 | 2,779 | 179,468 | 44,034 | 46.8 K to 44 K (-5.94 %) |
| Mar 06 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 24.51 | 1,651 | 40,466 | 46,813 | 48.5 K to 46.8 K (-3.41 %) |
| Mar 06 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 24.69 | 2,132 | 52,639 | 48,464 | 50.6 K to 48.5 K (-4.21 %) |
| Mar 06 2013 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Sell | S | 24.44 | 417 | 10,191 | 50,596 | 51 K to 50.6 K (-0.82 %) |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
| Nov 21 2011 | CLVS | Clovis Oncology, I ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Page: 1